MYND Life Sciences (OTCQB:MYNDF) announced removal of C$800,619.65 in loan and officer deferred salary debt and has been converted into shares of MYND Life Sciences.
This conversion is intended to align the interests of the company's leadership with its shareholders and to demonstrate a buy-in to MYND's vision and strategic plan.
The company also announced the appointment of Lana Hoogenboom to its Board of Directors.